Harrison.ai raises $112M for its AI medical diagnosis tools

Medical software startup Harrison-AI Pty Ltd. today announced that it has closed a $112 million funding round to enhance its technology.

​Aware Super, ECP and returning backer ​Horizons Ventures​ jointly led the Series C investment. The deal, which also included the participation of several other institutional backers, brings Harrison.ai’s total outside funding to more than $240 million.

Australia-based Harrison.ai develops software tools that use artificial intelligence to help clinicians diagnose medical conditions. The company’s first offering, Annalise.ai, is geared toward processing medical images such as CT scans. Harrison.ai’s other product is called Franklin.ai and focuses on helping pathologists analyze biopsy samples. 

The company developed Annalise.ai in collaboration with I-MED Radiology, an Australian operator of radiology labs. The software is available in two editions that each focus on a different set of tasks.

The first version, Annalise Enterprise CTB, helps medical professionals study head CT scans. Harrison.ai says that the software can automatically discover 130 types of clinical findings including multiple conditions that require rapid medical intervention. Typically, Annalise Enterprise CTB completes CT scan analyses in under two minutes.

To help radiologists study the findings surfaced by its AI algorithms, Annalise Enterprise CTB includes a console called Annalise Viewer. The feature automatically highlights the section of a medical image where the algorithms identify anomalies. According to Harris.ai, the software improves diagnostic accuracy by an average of 32% across the 130 types of medical findings it can surface.

The second edition of Annalise.ai, Annalise Enterprise CXR, is optimized to process chest X-rays. Harris.ai says that the software detects potential medical issues in under 20 seconds. The tool can boost clinicians’ diagnostic accuracy by 45% on average across the 124 types of clinical findings it’s capable of detecting. 

After identifying a medical condition, radiologists summarize their findings in a report that can be shared with colleagues. To speed up the task, both editions of Annalise.ai include an AI-powered drafting feature. It supports a dozen languages and enables medical teams to customize the format of the outputted draft report. 

Harrison.ai’s other core product is called Franklin.ai. It’s designed to help clinicians analyze images of biopsy samples. The software automates tasks such as finding objects of interest in an image, counting them and measuring their dimensions.

Franklin.ai also promises to ease so-called synoptic reporting. This is the process through which pathologists summarize medical findings in a standardized report format to ease analysis.

Harrison.ai says its software is used at more than 1,000 healthcare facilities worldwide. In Australia, every other radiologist has access to Annalise.ai. The software also helps process a significant percentage of the chest X-rays taken in the U.K.

The funding round announced today will enable Harrison.ai to grow its U.S. presence by opening an office in Boston. The company will also use the capital to expand beyond radiology and pathology to other medical fields. 

Photo: Pixabay